Suppr超能文献

原发性甲状腺功能减退症儿童期开始替代治疗后的追赶生长:它能否为特发性生长激素缺乏症的最佳生长激素治疗提供指导?

Catch-up growth after childhood-onset substitution in primary hypothyroidism: is it a guide towards optimal growth hormone treatment in idiopathic growth hormone deficiency?

作者信息

Ranke M B, Schwarze C P, Mohnike K, von Mühlendahl K E, Keller E, Willgerodt H, Kiess W

机构信息

University Children's Hospital, Tübingen, Germany.

出版信息

Horm Res. 1998;50(5):264-70. doi: 10.1159/000023288.

Abstract

Catch-up growth was analyzed in 20 prepubertal children with primary hypothyroidism (PH) starting treatment at an age of 4.4 (1.2-10.1) years and a height (HT) SD score (HT SDS) of -3.1 (+/-0.8). All patients were followed for at least 3 prepubertal years. HT velocity was 12.3 +/- 2.3, 9.0 +/- 1.8 and 7.5 +/- 2.2 cm/year, and change in HT SDS was 1.60 +/- 0.56, 0.57 +/- 0.33 and 0.28 +/- 0.38 during the 1st, 2nd and 3rd year, respectively. The 11 children followed to adult height reached a HT SDS of -0.11 +/- 1.1, all within their target HT range. HT gain (DeltaHT SDS) during the 1st year was correlated with the degree of catch-up growth (r2 = 0.78, p < 0.001). While catch-up growth in childhood-onset PH is complete, this is not the case in GH deficiency (GHD). Based on the auxological characteristics of the patients with PH, HT velocities during the first 2 years were predicted applying prediction models devised for prepubertal children with idiopathic GHD. The modalities of GH treatment observed in the models were used to calculate predicted HT velocities of the PH patients. Observed HT velocities in PH were higher than predicted HT velocities during the 1st (10.67 +/- 1.37 cm/year, p < 0.01) and 2nd (8.35 +/- 0.86 cm/year, p = 0.128) year. The data show that catch-up potential in idiopathic GHD of childhood onset is reduced compared to PH. Since early catch-up as well as total HT recovery in children with GHD are often not reached by present treatment modalities, catch-up growth in PH may serve as a model towards optimizing GH treatment. The data suggest that initial GH doses of 1.0 IU/kg/week, rather than the presently recommended 0. 6 IU/kg/week, need to be given in GHD in order to achieve the degree of early catch-up observed in PH and to consequently improve the final outcome.

摘要

对20名青春期前原发性甲状腺功能减退症(PH)患儿的追赶生长情况进行了分析,这些患儿开始治疗时的年龄为4.4(1.2 - 10.1)岁,身高(HT)标准差评分(HT SDS)为 -3.1(±0.8)。所有患者均接受了至少3年的青春期前随访。第1年、第2年和第3年的HT生长速度分别为12.3 ± 2.3、9.0 ± 1.8和7.5 ± 2.2厘米/年,HT SDS的变化分别为1.60 ± 0.56、0.57 ± 0.33和0.28 ± 0.38。随访至成人身高的11名儿童的HT SDS达到 -0.11 ± 1.1,均在其目标HT范围内。第1年的HT增长(ΔHT SDS)与追赶生长程度相关(r2 = 0.78,p < 0.001)。虽然儿童期发病的PH的追赶生长是完全的,但生长激素缺乏症(GHD)并非如此。根据PH患者的体格学特征,应用为青春期前特发性GHD患儿设计的预测模型预测了前2年的HT生长速度。模型中观察到的生长激素治疗方式被用于计算PH患者的预测HT生长速度。PH患者观察到的HT生长速度在第1年(10.67 ± 1.37厘米/年,p < 0.01)和第2年(8.35 ± 0.86厘米/年,p = 0.128)高于预测的HT生长速度。数据表明,与PH相比,儿童期发病的特发性GHD的追赶生长潜力降低。由于目前的治疗方式往往无法使GHD患儿实现早期追赶以及完全恢复HT,PH的追赶生长可能为优化生长激素治疗提供一个模型。数据表明,在GHD中,为了达到在PH中观察到的早期追赶程度并从而改善最终结果,需要给予1.0 IU/kg/周的初始生长激素剂量,而不是目前推荐的0.6 IU/kg/周。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验